sie - india deal postponed -- disappointing

  1. 4,229 Posts.
    lightbulb Created with Sketch. 255
    Despite a lengthier process than expected within the Indian Ministry of Health in the registration of SciGen's insulin in India, the process is now well under way and expected to conclude in the middle
    of this year with sales expected to commence in early FY 04 which is later than originally anticipated.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.